Jianmin Pharmaceutical Group (600976) Stock Overview

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. The company operates through Drug production and sales, Commercial, and Medical segments. It offers medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company also provides OTC and medical products, as well as consultation service. Further, it provides medical services, such as outpatient, hospitalization, and health management. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China.